Jeyes is to relocate up to 80 head office staff from its cleaning products production site in Thetford to a new office on the Cambridge Business Park in March. [23-Dec-2010]
Crown Paints, the Lancashire-based paint manufacturer with 1,400 staff, is expected to be put up for sale by private equity firm Endless with a valuation of £200m. [20-Dec-2010]
Aesica has acquired three pharmaceutical manufacturing plants in Germany and Italy from UCB, which will double the total size of its Newcastle-based business. [16-Dec-2010]
The Forensic Science Service is to close by 2012, affecting up to 1,600 jobs in Birmingham, Chepstow, Chorley, London, Huntingdon and Wetherby, and its work will be transferred to the private sector. [15-Dec-2010]
PsiOxus Therapeutics has announced the formation of a new Oxfordshire-based biotechnology group from the merger of Myotec Therapeutics with Hybrid Biosystems. [15-Dec-2010]
Aptuit is to close two pharmaceutical plants at Riccarton and Livingston in Scotland over the next year, with the loss of up to 340 jobs. [13-Dec-2010]
Reckitt Benckiser is to acquire Paras Pharmaceuticals, the Indian supplier of over-the-counter medicines with 700 staff, for £460m. [13-Dec-2010]
Yule Catto is to acquire PolymerLatex, the German manufacturer of emulsion polymer products, for £376m. [13-Dec-2010]
GRI Group has acquired Libra Chemicals, the Manchester-based chemicals manufacturer with 35 staff, and plans to double the size of the business by 2013. [09-Dec-2010]
West Pharmaceutical Services is to shed 220 jobs at its syringe products plant in St Austell over the next two years. [08-Dec-2010]
GlaxoSmithKline is to acquire Nanjing MeiRui Pharma Co, the Chinese pharmaceuticals manufacturer, for £44m. [08-Dec-2010]
Axis-Shield is to acquire the global clinical chemistry homocysteine operations of US-based Catch Incorporated for £6.3m. [07-Dec-2010]
Sinclair Pharma has acquired Cranage Healthcare, the Cheshire-based distributor of woundcare products, for an initial £0.4m. [06-Dec-2010]
Biotec Services International, the Bridgend-based pharmaceutical services firm, has undergone a management buy-out for undisclosed terms. [06-Dec-2010]
PolyBlend, the polymer manufacturer, has acquired a 27,000 sq ft manufacturing and warehouse site on Everite Road in Widnes. [06-Dec-2010]
EKF Diagnostics has acquired Argutus Medical, the Irish developer of novel biomarkers of organ injury, for £2.2m. [02-Dec-2010]
United Drug has acquired World Events Group, the provider of event management and marketing services to pharmaceutical manufacturers with more than 100 staff, for £13m. [02-Dec-2010]
Source BioScience has acquired ImaGenes, the German supplier of genomic products for manipulating gene and protein function, for £2m. [01-Dec-2010]
Dechra Pharmaceuticals has acquired Genitrix, the Billingshurst-based veterinary pharmaceuticals company, for an initial £5.4m. [01-Dec-2010]
GlaxoSmithKline is planning to create up to 1,000 new jobs in the UK, following research tax breaks that will enable it to invest £500m in the expansion of a factory in Hertfordshire and a new biopharmaceuticals plant. [30-Nov-2010]
Rivington Street Holdings is to acquire Quartzsite Medical and Biostability, in order to expand its new Isle of Man-based Athol Street Pharmaceuticals subsidiary. [29-Nov-2010]
Eden Biodesign is looking to expand the 90-strong workforce at its biopharmaceuticals plant in Speke with 35 new staff over the next few months. [25-Nov-2010]
Sika has selected DHL Supply Chain to handle the distribution of its speciality chemicals, with the consolidation of four warehouses onto a single site in Dunstable. [23-Nov-2010]
Aurelius of Germany has acquired a chemical production complex in Grangemouth from KemFine for undisclosed terms, with the transfer of up to 200 staff. [22-Nov-2010]
BTG is to acquire Biocompatibles, the Farnham-based supplier of drug devices, for £156m. [22-Nov-2010]
Novartis is planning to close its NeuTec Pharma research operation at Manchester Science Park, with the loss of up to 30 jobs. [22-Nov-2010]
Grosvenor Chemicals is seeking permission from Kirklees Council to rebuild the storage, office and laboratory facilities at its site in Linthwaite, following a recent fire. [22-Nov-2010]
Almac Group is continuing to recruit new staff at its pharmaceutical research and development operations in Northern Ireland, and currently has 100 vacancies across the group. [18-Nov-2010]
Reinnervate is planning to create 30 new jobs at its life sciences technology business in Sedgefield next year. [18-Nov-2010]
Omega Diagnostics is to acquire the in-vitro diagnostics division of Allergopharma Joachim Ganzer of Germany for £5m, with the transfer of 29 staff. [17-Nov-2010]
BioInnovel, the developer of bioprocess monitoring technologies, is to take space at the Innovation Accelerator Incubator laboratory being built at the Wilton Centre on Teesside. [17-Nov-2010]
AstraZeneca is looking to sell its Astra Tech dental implants and medical devices business for up to £1.2bn, having appointed JPMorgan to find a buyer. [16-Nov-2010]
Gen-Probe, the US biotechnology company, is to set up a £5m European headquarters in Manchester, extending its current site in Wythenshawe from 11,000 sq ft to 60,000 sq ft and creating 35 new jobs by 2012. [15-Nov-2010]
Monitor Coatings has secured £0.4m from the North-East Growth Fund to help expand its Tyneside-based industrial coatings business, including new equipment and an increase to the 34-strong workforce. [15-Nov-2010]
Syntaxin has raised £18m from investors to fund the commercial development of drugs to control cell secretion. [15-Nov-2010]
Procarta Biosystems of Norfolk has secured an equity investment of up to £1.2m to fund the development of a new class of DNA-based antibiotic. [10-Nov-2010]
Huntsman Corporation is to invest £3.5m in the expansion of production at its amines plant in Llanelli, securing the future of 46 jobs. [09-Nov-2010]
Sanofi Aventis has sold its pharmaceuticals plant in Alnwick to Covance of the US, with the transfer of 140 staff. [04-Nov-2010]
Protomed has secured a £1.5m equity investment from Quantum Pharmaceutical to fund the expansion of its Congleton-based medical packaging business, which currently has 12 staff. [04-Nov-2010]
Mitsubishi Chemical Corporation is to build a new £20m plant in Billingham to manufacture electrolytes for electric vehicle batteries by the end of next year. [28-Oct-2010]
Vickers Laboratories, the Leeds-based distributor of speciality chemicals with 22 staff, has undergone a management buy-out for undisclosed terms. [27-Oct-2010]
Novartis is to shed 190 of the 690 jobs at its plant in Speke, in order to transfer the packing of vaccines to Italy. [26-Oct-2010]
Dechra Pharmaceuticals is to acquire DermaPet, the US supplier of dermatological preparations for animals, for £40m. [25-Oct-2010]
Dow Chemical is to set up a supply chain design centre in Belfast, with the creation of 25 jobs. [20-Oct-2010]
Jeyes is planning to shed up to 36 of the 193 jobs at its cleaning products factory in Mold, in order to transfer its automatic packing operation to other sites. [18-Oct-2010]
BOC is to close its acetylene gas plant in Bristol, with the loss of 30 jobs. [18-Oct-2010]
Catalent is to shed a further 50 jobs at its pharmaceuticals plant in Swindon. [18-Oct-2010]
Redx Pharma has raised £1.9m from investors to create a new bioscience company at Merseybio in Liverpool, having acquired the assets of Bradford Pharma. [13-Oct-2010]
The European Medicines Evaluation Agency (EMEA) has shortlisted five potential sites in east London for a new 300,000 sq ft office. [12-Oct-2010]
Instem Life Science Systems has raised £9m in a share placing to fund the expansion of its Staffordshire-based business supplying IT systems to the pharmaceutical sector. [11-Oct-2010]
Convergence Pharmaceuticals has raised £22m from a syndicate of investors to fund the development of new pain-relief treatments. [07-Oct-2010]
Johnson Matthey is to acquire Intercat, the US supplier of fluid catalytic cracking additives with 180 staff, for £35m. [07-Oct-2010]
IS Pharma, the Chester-based supplier of pharmaceuticals and medical devices, has raised £3.6m in a share placing with Abingworth. [07-Oct-2010]
Alliance Boots is to shed 900 jobs from its contract manufacturing and health and beauty operations over the next three years, which will mainly affect its Nottingham headquarters. [05-Oct-2010]
Forensic Science Service has confirmed plans to close its Washington Hall laboratory in Euxton, Lancashire, in March 2011 with the loss of 200 jobs. [04-Oct-2010]
NanoTherics has raised £1.1m from investors to fund the expansion of its Staffordshire-based gene therapy research business. [04-Oct-2010]
Biocatalysts has announced plans to expand the 40-strong workforce at its enzyme manufacturing business near Caerphilly with 25 new jobs over the next five years. [30-Sep-2010]
Horizon Discovery has secured £6.2m of venture capital funding to expand its Cambridge-based biotechnology business. [29-Sep-2010]
Huntsman is to sell its EA West water treatment chemicals business to Industrial Chemicals, with the possible loss of 12 jobs in Grimsby. [28-Sep-2010]
Unilever is to acquire Alberto Culver, the US-based supplier of hair care and skin care products with 2,700 staff in nine countries, for £2.3bn. [27-Sep-2010]
PZ Cussons has acquired St Tropez Holdings, the supplier of sunless tanning products, from private equity firm LDC for £62m. [27-Sep-2010]
EKF Diagnostics is to acquire Quotient Diagnostics, the Surrey-based developer of diabetes monitoring devices, for an initial £3.4m. [23-Sep-2010]
ValiRx is to sell ValiBIO, its Belgian diagnostics subsidiary, to Singapore Volition for £0.6m. [23-Sep-2010]
Croda is planning a further multi-million pound investment at its polymer additives production plant in Hull. [23-Sep-2010]
Exwold Technology has secured a £1m investment to expand its chemicals manufacturing operations in Hartlepool and Billingham, including a new compaction plant and an increase to the 60-strong workforce. [22-Sep-2010]
Animalcare has confirmed the sale of its Fearing International and Ritchey agricultural operations to Tru-Test UK for £3.2m, in order to focus on veterinary medicines. [20-Sep-2010]
KemFine UK has been acquired by Aurelius of Germany for undisclosed terms, securing the future of up to 200 jobs at its chemicals production business in Grangemouth. [20-Sep-2010]
NeutraHealth, the Birmingham-based vitamins supplier, is to be acquired by Elder Pharmaceuticals of India for £12m. [20-Sep-2010]
Animalcare, the supplier of veterinary medicines, is in negotiations to sell its Fearing International and Ritchey agricultural operations. [14-Sep-2010]
Immunodiagnostic Systems has acquired MGP Diagnostics of Norway for undisclosed terms. [13-Sep-2010]
Thornton & Ross has acquired the Allens herbal remedies brand of Anglesey-based Allens & Co. [13-Sep-2010]
Corridor Manchester has selected a consortium of Bruntwood and Manchester Science Parks to develop a £21m biomedical research centre at the former Manchester Royal Eye Hospital by summer 2012, which will create 440 jobs. [07-Sep-2010]
Aesica is considering plans to close its pharmaceuticals plant in Ponders End, London, with the loss of up to 56 jobs. [06-Sep-2010]
Phagenesis of Manchester has raised £2m from investors to fund the commercial development of a new treatment for dysphagia. [02-Sep-2010]
McBride has acquired a 70% stake in Dermacol, the Czech manufacturer of skincare products with more than 100 staff, for £8m. [02-Sep-2010]
Warwick International is to sell its speciality chemicals distribution business, which has annual sales of £66m, to IMCD Group of the Netherlands. [01-Sep-2010]
The University of Edinburgh has secured a £10m donation to set up a new research clinic for multiple sclerosis. [01-Sep-2010]
ImmunoSolv of Edinburgh has merged with Grampian BioConsultants of Aberdeen for undisclosed terms, having secured additional funding from Grampian BioPartners and Scottish Enterprise. [31-Aug-2010]
Sinclair Pharma is to raise £19m in a share issue to fund the acquisition of licensing rights, reduce debt and develop certain technologies. [26-Aug-2010]
ClinTec International, the Glasgow-based drug-testing firm, has secured an £8m equity investment from Elephant Capital. [23-Aug-2010]
MedImmune, the biologics division of AstraZeneca, is setting up a new 22,000 sq ft office at Granta Park in Cambridge. [23-Aug-2010]
Aesica is to build a new £3m pharmaceutical production facility at its Queenborough site in Kent by May 2011. [18-Aug-2010]
Polar Speed Distribution is to relocate its Leicestershire-based pharmaceuticals business and 20 staff to a smaller site in Swadlincote, Derbyshire. [16-Aug-2010]
United Drug has acquired InforMed Group, the Macclesfield-based healthcare communications consultancy with 80 staff, for £11m. [12-Aug-2010]
Byotrol is to raise £3.7m in a share placing to fund the expansion of its Manchester-based hygiene products manufacturing business. [11-Aug-2010]
Vectura is to close its Ruddington pharmaceutical laboratories in Nottingham, affecting up to 100 jobs. [10-Aug-2010]
Cyprotex has acquired Apredica, the US pharmaceuticals research firm, for £2.7m. [09-Aug-2010]
Selby District Council has approved plans from Sedacol UK to develop a processing plant to produce distilled alcohol at the former Tate & Lyle site in Selby, with the creation of 50 jobs. [26-Jul-2010]
LGC Standards is to relocate its Bury-based testing laboratory and 45 staff to a 19,500 sq ft site on Carlyle Street in November. [21-Jul-2010]
M&A Pharmachem, the pharmaceuticals supplier, has acquired the 40,000 sq ft former Newsquest printing plant at Wingates Industrial Park in Bolton for £2m. [15-Jul-2010]
Cyprotex is to double the capacity at its pharmaceutical testing laboratory in Macclesfield, with the creation of ten jobs. [15-Jul-2010]
Kymab has secured £20m from the Wellcome Trust to develop antibody-based medicines at the Babraham Research Campus in Cambridge. [14-Jul-2010]
Merck is to close its MSD pharmaceuticals plant at Newhouse in Lanarkshire by the end of the year, with the loss of 250 jobs, and its Mildenhall site in Suffolk will also close. [12-Jul-2010]
FPCi is looking to expand the 65-strong workforce at its Stokesley-based organic chemicals and automotive components manufacturing business to 120 over the next two years. [12-Jul-2010]
Avacta has raised £1.4m in a share placing to fund the expansion of its York-based life sciences business. [07-Jul-2010]
Allergy Therapeutics is to acquire Teomed, the Swiss pharmaceuticals distributor with 12 staff, for £0.7m. [05-Jul-2010]
Aesica has acquired R5 Pharmaceuticals, the Nottingham-based pharmaceuticals manufacturer with 51 staff, for undisclosed terms. [01-Jul-2010]
Quintiles, the US pharmaceuticals firm, is to relocate its UK headquarters from Bracknell to a 120,000 sq ft office at Green Park in Reading. [21-Jun-2010]
Ineos Bio has unveiled plans to build a £52m waste-fuelled bioethanol plant at its Seal Sands site on Teesside by 2015, with the creation of 40 jobs. [15-Jun-2010]
Mentholatum has announced a multi-million pound investment in the expansion of its skin care products factory in East Kilbride, with the creation of 20 jobs. [15-Jun-2010]
GlaxoSmithKline has acquired Laboratorios Phoenix, the Argentinian pharmaceuticals company, for £172m. [14-Jun-2010]
Quay Pharma is creating 65 jobs at a new £2.7m pharmaceuticals research and development facility at Deeside in North Wales. [14-Jun-2010]
LGC Group is planning to upgrade the facilities at its forensic laboratory at Risley near Warrington, and 40 staff will relocate from its site in Runcorn. [10-Jun-2010]
Proteome Sciences has raised £4.8m in a share placing to fund an investment in new equipment for its Biomarker Services division. [08-Jun-2010]
Tissue Regenix is to float its York-based tissue replacement business on Aim through a reverse takeover of Oxeco, which will raise £4.5m in new funds. [03-Jun-2010]
Respivert, the London-based drug discovery company, has been sold by Imperial Innovations to Centocor Ortho Biotech for £9.5m. [01-Jun-2010]
Martindale Pharmaceuticals has been sold by Cardinal Health to private equity firm AAC Capital for about £100m. [01-Jun-2010]
Johnson Matthey is planning to close its Vertec inks, paints and polymers business in Billingham, with the loss of 50 jobs. [01-Jun-2010]
Reinnervate has secured about £1.6m of venture capital funding to expand its Durham-based cell culture biotechnology business. [01-Jun-2010]
AssayMetrics has secured an undisclosed equity investment from Finance Wales to fund the commercial development of its Cardiff-based chemical dyes business. [27-May-2010]
The Wilton Centre on Teesside is to start work on the development of a 10,000 sq ft Innovation Accelerator Incubator, which will create up to 100 jobs at ten new laboratory units. [20-May-2010]
TPP Global Development is to set up a headquarters for its new life sciences business at the Edinburgh BioQuarter, with the creation of an initial 15 jobs. [20-May-2010]
Pfizer is to shed 6,000 jobs worldwide, including 90 of the 400 at its vaccine packaging and distribution plant in Havant. [19-May-2010]
Celgene is said to be considering plans to relocate its pharmaceuticals business from Windsor to a 50,000 sq ft office at Stockley Park in West London. [17-May-2010]
Paragon Inks is to relocate its Broxburn-based printing inks business and 37 staff to a new £3.5m headquarters at Starlaw Park near Bathgate in November. [17-May-2010]
Veeda Clinical Research has shed 32 of the 47 jobs at its drug safety trials business in Plymouth. [17-May-2010]
Bio-D, the Hull-based developer of environmentally-friendly cleaning products, has undergone a management buy-out. [12-May-2010]
Croda is to sell its oleochemicals production site at Emmerich in Germany to KLK Group for £55m. [11-May-2010]
Oxford Immunotec has raised £17m to fund its sales and marketing activities and the development of new diagnostic tests. [06-May-2010]
ZooBiotic of Bridgend has acquired BioMonde of Germany for undisclosed terms, creating a combined wound healing group with annual sales of £5m. [06-May-2010]
Bayer is investing £10m in improvements to its crop chemicals site in Norwich, securing the future of 280 jobs. [28-Apr-2010]
Celanese is considering plans to close its chemicals factory in Spondon by the end of next year, with the loss of up to 460 jobs. [28-Apr-2010]
The University of Leicester is planning to build a new £15m drug testing laboratory by early 2011. [27-Apr-2010]
Multisol Group, the Cheshire-based chemicals distribution firm with more than 120 staff, is considering its strategic options, which could lead to a flotation on Aim. [26-Apr-2010]
Randox Laboratories is to continue to expand the 850-strong workforce at its Crumlin-based medical diagnostics business over the coming months. [26-Apr-2010]
Warner Chilcott has announced a £6.6m investment in the expansion of its pharmaceuticals research facility in Larne, supported by £1.7m from Invest NI. [26-Apr-2010]
Neolab has secured £2m of venture capital from Maven Capital Partners to fund the expansion of its Hampshire-based pharmaceuticals licensing business. [22-Apr-2010]
Neuropharm, the Leatherhead-based pharmaceutical research firm, is to go into voluntary liquidation. [21-Apr-2010]
Kay-Metzeler is considering plans to close its polyurethane foams operation at Bollington in Cheshire by 2011, with the loss of up to 60 jobs. [21-Apr-2010]
University of Aberdeen has secured £2.6m of European funding to develop a £5.8m life sciences business centre, with the creation of 69 jobs. [20-Apr-2010]
Wellcome Trust is to provide an additional £110m of funding to pharmaceutical companies and academics for the development of new drugs. [19-Apr-2010]
BASF is to shed 232 jobs at its Ciba synthetic dyes plant in Paisley by 2013, leaving a workforce of 120. [13-Apr-2010]
Novartis is hoping to win government support to upgrade its vaccines plant in Speke within five years, in order to secure the future of 750 jobs. [13-Apr-2010]
Apex Speciality Solutions is looking to expand the 40-strong workforce at its Aberdeen-based chemicals distribution business with about ten new jobs. [08-Apr-2010]
Intertek has acquired Ciba Expert Services, the Swiss pharmaceutical and chemical safety testing firm with 200 staff and an office in Macclesfield, from BASF for undisclosed terms. [07-Apr-2010]
Merck Sharp & Dohme is considering plans to shed up to 40 jobs at its pharmaceuticals factory in Cramlington. [01-Apr-2010]
Colony Gift Corporation, the manufacturer of home fragrance products with about 170 staff, is to invest £1m in the expansion of its factory in Ulverston over the next year. [31-Mar-2010]
Medical Research Council has secured £250m of government funding to develop a biomedical science research laboratory at St Pancras in London by 2015. [29-Mar-2010]
Aquapharm Biodiscovery has raised £4.2m from investors to fund the expansion of its Oban-based marine biotechnology business. [29-Mar-2010]
Avon has acquired Liz Earle Beauty, the Isle of Wight-based skincare firm with 300 staff, for undisclosed terms. [29-Mar-2010]
Industrial Chemicals has acquired a 35-acre chemical production site in Selby from Clariant Production for undisclosed terms, and will use it as an additional manufacturing facility. [22-Mar-2010]
AstraZeneca is to shed an unspecified number of the 225 jobs at its accounting office in Manchester, in order to outsource some back office functions to Genpact. [15-Mar-2010]
Irish Salt Mining & Exploration has won approval to extend its salt mine near Carrickfergus, securing 54 jobs and creating up to ten new jobs. [15-Mar-2010]
Polartech, the Manchester-based supplier of chemicals to the metalworking industry with 130 staff, has been acquired by Afton Chemical Corporation of the US for undisclosed terms. [15-Mar-2010]
Centre for Process Innovation is to create up to 40 jobs at a new £12m industrial biotechnology testing centre due to open at Wilton on Teesside later this year. [15-Mar-2010]
Syntopix is to raise a further £2m in a share placing to fund the expansion of its Bradford-based skin care products business. [15-Mar-2010]
Membrane Extraction Technology, the London-based chemical separation products supplier, has been acquired by Evonik Industries of Germany for about £4m. [10-Mar-2010]
Hallam Beauty, the Bradford-based manufacturer of personal care products, has been acquired by Mibelle for undisclosed terms. [09-Mar-2010]
Alliance Boots is creating 50 jobs at its new BCM Specials bespoke medicines laboratory in Nottingham. [08-Mar-2010]
Ineos is considering plans to relocate the headquarters of its chemicals business from the UK to Switzerland, in order to save up to £400m over the next four years. [04-Mar-2010]
Stemgent of the US is to invest £3m in the development of a new cancer drugs research facility called Ubiquigent in Dundee over the next three years. [04-Mar-2010]
Avacta has acquired Reactivlab, the Glasgow-based veterinary diagnostics firm, for up to £5m. [04-Mar-2010]
AstraZeneca is to close its pharmaceuticals research unit at Charnwood in Leicestershire next year with the loss of up to 1,000 jobs, and a further 70 jobs will be lost at its research unit in Avonmouth. [03-Mar-2010]
Deb Group, the skincare and cleaning products manufacturer with 220 staff in Derbyshire, has undergone a £325m management buy-out backed by Charterhouse Capital. [03-Mar-2010]
Allergy Therapeutics has raised £2m in a share placing to fund the expansion of its Worthing-based allergy vaccines business. [03-Mar-2010]
ApaTech, the Hertfordshire-based synthetic bone developer, is to be acquired by Baxter International of the US for up to £222m. [02-Mar-2010]
Archimedes Pharma has secured a £65m equity investment to fund the expansion of its Reading-based pharmaceuticals business, including the global launch of a pain relief spray. [02-Mar-2010]
Plant Impact has raised £2m in a share placing to fund the expansion of its Preston-based organic fertilisers business, including the recruitment of new sales and marketing staff. [01-Mar-2010]
Ineos ChlorVinyls is to close its PVC plant in Barry, in order to consolidate production at sites in Runcorn and Newton Aycliffe. [01-Mar-2010]
Leeds Skin Care is relocating its skincare laboratory service from the University of Leeds to the Sandbeck Lane industrial estate in Wetherby. [24-Feb-2010]
Koch Fertilizer Trading has reached agreement with the Bristol Port Company to add a further 25,000 tonnes of storage capacity at its fertiliser terminal in Avonmouth by the end of the year. [24-Feb-2010]
GlaxoSmithKline is looking to create 1,000 new jobs in the UK, as part of a £500m investment in the life sciences sector that follows a government decision to cut taxes on revenues from patents. [23-Feb-2010]
Genzyme is to expand its life sciences research facility at Cambridge Science Park with an additional 10,000 sq ft of laboratory and office space. [22-Feb-2010]
Immune Targeting Systems of London has raised £8.6m to fund clinical trials for the development of virus vaccines. [22-Feb-2010]
Excelsyn, the North Wales-based provider of manufacturing services to pharmaceutical companies with 60 staff, has been acquired by Albany Molecular Research of the US for £12m. [22-Feb-2010]
Ineos, the chemicals manufacturer, has won approval from the National Park Authority to build a new office for up to 150 staff at Lyndhurst in the New Forest. [22-Feb-2010]
Travik Chemicals is planning to relocate its speciality chemical manufacturing business from County Durham to Tockwith near York. [18-Feb-2010]
KemFine, the agricultural chemicals manufacturer with about 460 staff in Grangemouth and Finland, is expected to be put up for sale by private equity owner 3i. [16-Feb-2010]
Oxford Nutrascience has raised £1.1m in an initial public offering to fund the commercial development of its tablets and syrups. [15-Feb-2010]
GlaxoSmithKline is planning to relocate more than 40 nutritional healthcare research jobs from Coleford to Brentford later this year, and a similar number of jobs will relocate from its site in Slough. [15-Feb-2010]
Vernalis has raised £25m in a share placing to fund the expansion of its pharmaceuticals research business. [15-Feb-2010]
Glide Pharma of Didcot has secured a further £2.7m of venture capital to fund the commercial development of needle-free drug delivery systems. [15-Feb-2010]
Fillcare is to invest £7m in the expansion of the former L'Oreal cosmetics factory in Llantrisant, with the creation of almost 200 jobs over the next four years. [11-Feb-2010]
GlaxoSmithKline is to shed about 380 of the 1,150 jobs at its pharmaceuticals research centre at Harlow in Essex, having decided to stop developing new depression and pain medicines. [11-Feb-2010]
Exosect, the Hampshire-based agrochemicals company, has raised £2.2m from investors to fund the commercial development of its pest control products. [09-Feb-2010]
Alliance Pharma is to acquire the trade and assets of Cambridge Laboratories for up to £16m, with the transfer of about 30 staff in Newcastle and Dublin. [09-Feb-2010]
LGC, the forensic research group with 1,500 staff at 28 biological and chemical laboratories, is to be acquired by Bridgepoint for £257m. [08-Feb-2010]
Ineos Fluor is to sell its Runcorn-based fluorochemicals business to Mexichem of Mexico for an estimated £220m, with the transfer of about 280 staff. [08-Feb-2010]
The Institute of Biological, Environmental & Rural Sciences (Ibers) is planning to shed up to 70 jobs at its plant research centre at Aberystwyth University. [08-Feb-2010]
Dow Chemical is to close one of the production lines at its recently-acquired chemicals plant in Jarrow, with the loss of eight of the 58 jobs. [08-Feb-2010]
Anglian Chemicals has been bought out of administration by a former owner, securing 25 jobs at its cleaning chemicals manufacturing business in Fakenham. [04-Feb-2010]
Angel Biotechnology has raised £1.4m in a share placing to fund the expansion of capacity at its facility in Edinburgh. [04-Feb-2010]
Thompson & Morgan has acquired Chempak, the Ipswich-based supplier of plant foods, for undisclosed terms. [04-Feb-2010]
GlaxoSmithKline is looking to shed more than 3,000 jobs from its 99,000-strong global workforce, which is likely to affect some of its six research and development sites in the UK. [01-Feb-2010]
Oxford Nanopore has raised £17m from investors to fund the commercial development of its DNA mapping technology. [01-Feb-2010]
AstraZeneca is planning to shed 8,000 jobs from its global pharmaceuticals business over the next four years, which could affect research and development sites in Macclesfield, Charnwood and Cambridge. [01-Feb-2010]
Crown Paints has secured a £25m funding package to invest in expansion opportunities for its Lancashire-based paint manufacturing business. [01-Feb-2010]
ICI-Imagedata, the coatings manufacturer with 50 staff, has been acquired by Illinois Tool Works of the US for undisclosed terms. [01-Feb-2010]
The Biotechnology & Biological Sciences Research Council (BBSRC) is to open new laboratory and office facilities for up to 300 research scientists at Norwich Research Park this summer. [28-Jan-2010]
Lonza Group, the pharmaceuticals company, is to close offices in Wokingham, Canada and the US, with the loss of 175 jobs. [21-Jan-2010]
Randox Laboratories is planning to create 23 new jobs at its diagnostic test products business in County Antrim. [20-Jan-2010]
International Paint is to invest £6.4m in a new fire protection products testing laboratory at its site in Gateshead by 2011, with the creation of 14 jobs. [19-Jan-2010]
AstraZeneca is said to be planning to set up a 55,000 sq ft office at Stockley Park near Heathrow. [18-Jan-2010]
Cleveland Potash has unveiled proposals to set up a nationwide network of salt depots, in order to help local authorities with road gritting in winter. [18-Jan-2010]
Waymade Healthcare is planning to expand the 14-strong workforce at its new £1m pharmaceuticals factory in Basildon to 28 by the end of the year. [13-Jan-2010]
Vireol is linking up with Future Capital Partners and Simon Carves to proceed with plans for the development of a £236m bioethanol plant in Grimsby, which will create more than 50 jobs. [13-Jan-2010]
Proximagen Neuroscience is to acquire Minster Pharmaceuticals, the London-based drug development company, for £4.3m. [05-Jan-2010]